Filter News

MicroRNA (miRNA) Market Size to Reach USD 516.9 Million in 2028 – Reports and Data

Published: Jun 30, 2021

Rising investments in the development of advanced microRNA techniques and tools contribute to the global market growth

The global microRNA (miRNA) market size is expected to reach USD 516.9 million by 2028 at a CAGR of 11.6%, according to a new report by Reports and Data. Significant revenue growth is mainly attributed to increasing research & development programs on genomics and RNA biology, rise in adoption of high-throughput miRNA analysis techniques, and emergence of next-generation miRNA sequencing techniques. Rising prevalence of chronic disorders such as cancer, increasing infectious disease outbreaks such as the ongoing COVID-19 pandemic, and growing applications of miRNA in the pharmaceutical and biotechnology sectors are other key factors responsible for market growth. Furthermore, major advancements in gene sequencing technologies and rise in government investments in life sciences R&D activities bolster the global microRNA (miRNA) market growth.

A microRNA (miRNA) is a small, single-stranded RNA molecule present in animals, plants, and different viruses. Post-transcriptional regulation of gene expression and RNA silencing are two of the key functional areas of miRNAs. miRNAs complement messenger RNA (mRNA) in down-regulating the gene expression and also regulate several vital cellular functions such as cell differentiation, proliferation, and apoptosis. Besides identifying different cell types, they play an indispensable role in cell physiology and development and various pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. miRNAs are present in various mammalian cell types in large numbers. MicroRNA sequencing is a form of RNA sequencing that involves next-generation DNA sequencing technology and is performed by researchers to study miRNA isoforms, tissue-specific expression patterns, and disease associations.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1418

Some Key Highlights in the Report:

  • Based on product type, the kits, reagents, and consumables segment emerged as the most dominant segment in 2020, with the highest revenue share of over 60%. Growth of this segment can be attributed to extensive use of detection kits, consumables, qPCR primers, and transfection reagents miRNA profiling and analysis due to their non-durable nature.
  • The RT-PCR research tools segment was the most dominant in 2020 and accounted for a revenue share of around 33% in the global microRNA (miRNA) market. High reliability and sequence specificity of this technique for detection of miRNA expression, increasing applications of RT-PCR in miRNA profiling, quantitation, validation, and analysis, and rapidly increasing volumes of RT-PCR tests for COVID-19 are the key factors driving the growth of this segment.
  • North America accounted for the highest revenue share of around 45% in the global microRNA (miRNA) market in 2020. Market growth in this region is accelerated by increasing research & development activities in the fields of genomics, proteomics, and oncology, introduction of advanced miRNA biomarkers, increasing R&D investments in the biotechnology and biopharmaceutical industries, and the state-of-the-art healthcare infrastructure in North America.
  • Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific are among the leading competitors in the global microRNA (miRNA) market.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1418

For the purpose of this report, the global microRNA (miRNA) market is segmented on the basis of product type, research tools and services, application, end-use, and region:

Product Type Outlook (Revenue, USD Million; 2018-2028)

  • Instruments
  • Kits, Reagents, and Consumables
  • Isolation & Purification
  • Quantification & Detection
  • Functional Analysis
  • Others

Research Tools and Services Outlook (Revenue, USD Million; 2018-2028)

  • Tools
  • RT-PCR
  • Biomarkers
  • Next Gen Sequencing (NGS)
  • Microarray Analysis Tools
  • Functional Analysis Tools
  • Extraction Tools
  • Others
  • Services
  • miRNA cDNA Synthesis
  • Quantification Services
  • Microarray Services
  • Sequencing Services
  • Functional Studies Services
  • Others

Application Outlook (Revenue, USD Million; 2018-2028)

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1418

End-use Outlook (Revenue, USD Million; 2018-2028)

  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Diagnostic Centers

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Computational Biology Market Analysis, By Service (In-house, Contact), By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modeling), By End-Use (Academics, Industrial, Commercial), And Segment Forecasts To 2027

Cell Isolation Market Analysis, By Product (Instruments), By Cell Type (Human), By Technique (Surface Marker), By Application (Biomolecule Isolation, Cancer Research), By End Use (Research laboratories and institutes) and By Region, Forecasts to 2026

Mycoplasma Testing Market Analysis, By Product Type (Instruments, Kits & Reagents) By Technology Type (PCR, ELISA, Direct Assay, And Others) By Application Type (Cell Line, Virus) By End Use (Pharmaceutical Companies, Cell Banks), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-microrna-mirna-market

Back to news